Since its inception in 1940, Weifa has grown into one of Norway’s leading suppliers of medicines and lifestyle products.

Karo Pharma commences voluntary cash offer to acquire the entire issued share capital of Weifa. The Offer document, containing the complete terms and conditions of the Offer, was published 11th September by Karo Pharma. Subject to restrictions under applicable securities laws, the Offer document will be distributed to all shareholders listed in Weifa's share register and will also be available at www.dnb.no/emisjoner